Institut Gustave Roussy
| Gustave Roussy | |
|---|---|
 | |
| Geography | |
| Location | Villejuif, France |
| Organisation | |
| Type | Research center, Teaching Hospital |
| Services | |
| Emergency department | Yes |
| Beds | 457 |
| History | |
| Opened | 1926 |
| Links | |
| Website | https://www.gustaveroussy.fr/en |
| Lists | Hospitals in France |
Gustave Roussy is one of the world’s leading cancer-research institutes and the premier European Cancer Centre. It is a centre for patient care, research and teaching, and patients with all types of cancer can be treated there.
It is located in Villejuif, South Paris, France. It is named after Gustave Roussy, a Swiss-French neuropathologist.
Notable employees
- Gustave Roussy, first director (1921–1947)
- Tabaré Vázquez
- Maurice Tubiana, fifth director (1982–1988) and member of the French Academy of Sciences
- Georges Mathé, oncologist and immunologist who performed in 1959 the first successful bone marrow transplant not performed on identical twins.[1]
- Frédéric Triebel, discoverer of the immune checkpoint molecule LAG3, worked at the Institute from 1986 until around 2001
Incidents
In 2014, a virologist was sentenced to 5 years in prison for poisoning colleagues with sodium azide[2].
Notes
- ^ Martin, Douglas (20 October 2010). "Dr. Georges Mathé, Transplant Pioneer, Dies at 88". New York Times.
- ^ "A l'Institut Gustave-Roussy, un scientifique empoisonne ses collègues". Franceinfo (in French). 2017-12-13. Retrieved 2018-09-10.